XTX Topco’s BioCardia BCDA Stock Holding History

XTX Topco’s Portfolio BCDA Stock Details BCDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$29.4K	Buy	24,270 +7,980	+49%	+$9.98K	﹤0.01%	3458
2025 Q4	$20.4K	Buy	16,290 +113	+0.7%	+$153	﹤0.01%	3057
2025 Q3	$20.9K	Buy	+16,177	New	+$31.6K	﹤0.01%	2323

Other funds holding BCDA

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Pingora Partners Wilson, Wyoming $169M AUM 56.08% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

XTX Topco's BCDA Position: Q1 2026 in Review

XTX Topco increased its BioCardia (BCDA) stake by 49% in Q1 2026, buying an estimated $9.98K and bringing the position to 24,270 shares worth $29.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3458.

XTX Topco first reported a position in BCDA in Q3 2025 and has held it in 3 quarters since. 18 funds tracked by Wall St. Rank hold BCDA as of Q1 2026.

XTX Topco held 24,270 shares of BioCardia worth $29.4K as of Q1 2026.
XTX Topco bought 7,980 BioCardia shares in Q1 2026, an estimated $9.98K.
BioCardia made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3458 holding.
XTX Topco first reported a position in BioCardia in Q3 2025 and has held it in 3 quarters since.
18 funds tracked by Wall St. Rank held BioCardia as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.